These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 27699543)
1. Predictive Factors for Outcome and Quality of Life in HPV-Positive and HPV-Negative HNSCC. Hess J Recent Results Cancer Res; 2017; 206():233-242. PubMed ID: 27699543 [TBL] [Abstract][Full Text] [Related]
2. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma. Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438 [TBL] [Abstract][Full Text] [Related]
3. [Human papillomavirus and squamous cell cancer of the head and neck region : Prognostic, therapeutic and prophylactic implications]. Reuschenbach M; Wagner S; Würdemann N; Sharma SJ; Prigge ES; Sauer M; Wittig A; Wittekindt C; von Knebel Doeberitz M; Klussmann JP HNO; 2016 Jul; 64(7):450-9. PubMed ID: 26864190 [TBL] [Abstract][Full Text] [Related]
4. DETECTION OF HUMAN PAPILLOMA VIRUS IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS: A LITERATURE REVIEW. Jelihovschi I; Bidescu AC; Tucaliuc SE; Iancu LS Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):502-9. PubMed ID: 26204659 [TBL] [Abstract][Full Text] [Related]
5. Elevated intrinsic cancer stem cell population in human papillomavirus-associated head and neck squamous cell carcinoma. Zhang M; Kumar B; Piao L; Xie X; Schmitt A; Arradaza N; Cippola M; Old M; Agrawal A; Ozer E; Schuller DE; Teknos TN; Pan Q Cancer; 2014 Apr; 120(7):992-1001. PubMed ID: 24382806 [TBL] [Abstract][Full Text] [Related]
6. Systemic Treatment in HPV-Induced Recurrent or Metastatic HNSCC. Rieke DT; Keilholz U Recent Results Cancer Res; 2017; 206():149-160. PubMed ID: 27699536 [TBL] [Abstract][Full Text] [Related]
7. The New Face of Head and Neck Cancer: The HPV Epidemic. Lewis A; Kang R; Levine A; Maghami E Oncology (Williston Park); 2015 Sep; 29(9):616-26. PubMed ID: 26384796 [TBL] [Abstract][Full Text] [Related]
8. HPV Integration in Head and Neck Squamous Cell Carcinomas: Cause and Consequence. Speel EJ Recent Results Cancer Res; 2017; 206():57-72. PubMed ID: 27699529 [TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus (HPV) and oropharyngeal squamous cell carcinoma. Dalianis T Presse Med; 2014 Dec; 43(12 Pt 2):e429-34. PubMed ID: 25455638 [TBL] [Abstract][Full Text] [Related]
10. Human Papillomavirus (HPV): A Criterion for Therapeutic Decision in Squamous Cell Carcinoma of the Head and Neck? Vermorken JB Recent Results Cancer Res; 2017; 206():137-147. PubMed ID: 27699535 [TBL] [Abstract][Full Text] [Related]
11. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients. Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781 [TBL] [Abstract][Full Text] [Related]
12. The pathology of HPV-related head and neck cancer: implications for the diagnostic pathologist. Westra WH Semin Diagn Pathol; 2015 Jan; 32(1):42-53. PubMed ID: 25804343 [TBL] [Abstract][Full Text] [Related]
13. Molecular Patterns and Biology of HPV-Associated HNSCC. Brakenhoff RH; Wagner S; Klussmann JP Recent Results Cancer Res; 2017; 206():37-56. PubMed ID: 27699528 [TBL] [Abstract][Full Text] [Related]
14. [Research progress in pathogenesis, treatment and prognosis of HPV positive head and neck squamous cell carcinoma]. Shui CY; Li C; Liu W; Cai YC; Jiang J; Sun RH; Zhou YQ; Qin G Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):392-396. PubMed ID: 29764025 [TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma. Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365 [TBL] [Abstract][Full Text] [Related]
16. Risk Groups for Survival in HPV-Positive and HPV-Negative OPSCC. Rietbergen MM; Brakenhoff RH; René Leemans C Recent Results Cancer Res; 2017; 206():221-231. PubMed ID: 27699542 [TBL] [Abstract][Full Text] [Related]
17. Cancer Immunology and HPV. Wollenberg B Recent Results Cancer Res; 2017; 206():243-248. PubMed ID: 27699544 [TBL] [Abstract][Full Text] [Related]
18. The interplay between HPV and host immunity in head and neck squamous cell carcinoma. Andersen AS; Koldjaer Sølling AS; Ovesen T; Rusan M Int J Cancer; 2014 Jun; 134(12):2755-63. PubMed ID: 23913554 [TBL] [Abstract][Full Text] [Related]
19. Treatment outcomes in veterans with HPV-positive head and neck cancer. Feinstein AJ; Shay SG; Chang E; Lewis MS; Wang MB Am J Otolaryngol; 2017; 38(2):188-192. PubMed ID: 28342482 [TBL] [Abstract][Full Text] [Related]
20. HPV-Related Head and Neck Squamous Cell Carcinomas. Marszałek A; Szylberg Ł Recent Results Cancer Res; 2017; 206():89-100. PubMed ID: 27699531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]